menu
    • menu

    Company profile for Medicines360

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicines360's mission is to expand access to medicines for women regardless of their socioeconomic status, insurance coverage, or geographic location. Our work is focused on addressing the gaps women face in accessing the medicines they need. We use the proceeds from our first product to offer it at a very low price to healthcare providers who care for the underserved.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicines360United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Medicines360 San Francisco, CA 94111
    Telephone
    Telephone
    +1-415-951-8700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medicines360.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medicines360/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Medicines360?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicines360 Gains Rights to PeriPeach, Boosts Maternal Health
    Medicines360 Gains Rights to PeriPeach, Boosts Maternal Health

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150719/0/en/Medicines360-acquires-global-rights-to-PeriPeach-advancing-new-maternal-health-technology-through-the-360-Innovation-Hub.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Medicines360 Appoints Erica Rogers to Board of Directors
    Medicines360 Appoints Erica Rogers to Board of Directors

    10 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/10/2860573/0/en/Medicines360-Appoints-Erica-Rogers-to-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Apr 2024
    Share Share
    Medicines360 and DKT WomanCare Announce Strategic Partnership
    Medicines360 and DKT WomanCare Announce Strategic Partnership

    31 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/01/31/2821272/0/en/Medicines360-and-DKT-WomanCare-Announce-Strategic-Partnership-to-Expand-Access-to-the-Hormonal-IUD-Avibela.html

    GLOBENEWSWIRE
    31 Jan 2024
    Share Share
    Medicines360 & Allergan Present 6Y Clinical Data from Largest Ongoing Ph 3 Study
    Medicines360 & Allergan Present 6Y Clinical Data from Largest Ongoing Ph 3 Study

    06 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medicines360-and-allergan-present-six-year-clinical-data-from-largest-ongoing-phase-3-study-of-an-intrauterine-system-in-the-us-300843478.html

    PR NEWSWIRE
    06 May 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search